The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Morphine-Global Market Insights and Sales Trends 2024
Synopsis
The global Morphine market size is expected to reach US$ 26050 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Morphine in various end use industries. The expanding demands from the Anesthesia, Cough Suppressant and Diarrhea Suppressant,, are propelling Morphine market. Oral Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Morphine market, driven by demand from China, the second largest economy with some signs of stabilising, the Morphine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Morphine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Morphine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Morphine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Morphine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Morphine covered in this report include Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Sanofi Winthrop Industrie, Macfarlan Smith, Sun Pharmaceutical Industries, Qinghai Pharmaceutical and Northeast Pharmaceutical Group, etc.
The global Morphine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Sanofi Winthrop Industrie
Macfarlan Smith
Sun Pharmaceutical Industries
Qinghai Pharmaceutical
Northeast Pharmaceutical Group
Global Morphine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Morphine market, Segment by Type:
Oral Tablets
Injection
Capsule
Others
Global Morphine market, by Application
Anesthesia
Cough Suppressant
Diarrhea Suppressant
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Morphine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Morphine market size is expected to reach US$ 26050 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Morphine in various end use industries. The expanding demands from the Anesthesia, Cough Suppressant and Diarrhea Suppressant,, are propelling Morphine market. Oral Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Morphine market, driven by demand from China, the second largest economy with some signs of stabilising, the Morphine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Morphine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Morphine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Morphine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Morphine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Morphine covered in this report include Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Sanofi Winthrop Industrie, Macfarlan Smith, Sun Pharmaceutical Industries, Qinghai Pharmaceutical and Northeast Pharmaceutical Group, etc.
The global Morphine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Sanofi Winthrop Industrie
Macfarlan Smith
Sun Pharmaceutical Industries
Qinghai Pharmaceutical
Northeast Pharmaceutical Group
Global Morphine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Morphine market, Segment by Type:
Oral Tablets
Injection
Capsule
Others
Global Morphine market, by Application
Anesthesia
Cough Suppressant
Diarrhea Suppressant
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Morphine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Morphine Market Overview
1.1 Morphine Product Overview
1.2 Morphine Market Segment by Type
1.2.1 Oral Tablets
1.2.2 Injection
1.2.3 Capsule
1.2.4 Others
1.3 Global Morphine Market Size by Type
1.3.1 Global Morphine Market Size Overview by Type (2018-2029)
1.3.2 Global Morphine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Morphine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Morphine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Morphine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Morphine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Morphine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Morphine Sales Breakdown by Type (2018-2023)
2 Global Morphine Market Competition by Company
2.1 Global Top Players by Morphine Sales (2018-2023)
2.2 Global Top Players by Morphine Revenue (2018-2023)
2.3 Global Top Players by Morphine Price (2018-2023)
2.4 Global Top Manufacturers Morphine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Morphine Market Competitive Situation and Trends
2.5.1 Morphine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Morphine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Morphine as of 2022)
2.7 Date of Key Manufacturers Enter into Morphine Market
2.8 Key Manufacturers Morphine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Morphine Status and Outlook by Region
3.1 Global Morphine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Morphine Historic Market Size by Region
3.2.1 Global Morphine Sales in Volume by Region (2018-2023)
3.2.2 Global Morphine Sales in Value by Region (2018-2023)
3.2.3 Global Morphine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Morphine Forecasted Market Size by Region
3.3.1 Global Morphine Sales in Volume by Region (2024-2029)
3.3.2 Global Morphine Sales in Value by Region (2024-2029)
3.3.3 Global Morphine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Morphine by Application
4.1 Morphine Market Segment by Application
4.1.1 Anesthesia
4.1.2 Cough Suppressant
4.1.3 Diarrhea Suppressant
4.2 Global Morphine Market Size by Application
4.2.1 Global Morphine Market Size Overview by Application (2018-2029)
4.2.2 Global Morphine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Morphine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Morphine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Morphine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Morphine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Morphine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Morphine Sales Breakdown by Application (2018-2023)
5 North America Morphine by Country
5.1 North America Morphine Historic Market Size by Country
5.1.1 North America Morphine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Morphine Sales in Volume by Country (2018-2023)
5.1.3 North America Morphine Sales in Value by Country (2018-2023)
5.2 North America Morphine Forecasted Market Size by Country
5.2.1 North America Morphine Sales in Volume by Country (2024-2029)
5.2.2 North America Morphine Sales in Value by Country (2024-2029)
6 Europe Morphine by Country
6.1 Europe Morphine Historic Market Size by Country
6.1.1 Europe Morphine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Morphine Sales in Volume by Country (2018-2023)
6.1.3 Europe Morphine Sales in Value by Country (2018-2023)
6.2 Europe Morphine Forecasted Market Size by Country
6.2.1 Europe Morphine Sales in Volume by Country (2024-2029)
6.2.2 Europe Morphine Sales in Value by Country (2024-2029)
7 Asia-Pacific Morphine by Region
7.1 Asia-Pacific Morphine Historic Market Size by Region
7.1.1 Asia-Pacific Morphine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Morphine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Morphine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Morphine Forecasted Market Size by Region
7.2.1 Asia-Pacific Morphine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Morphine Sales in Value by Region (2024-2029)
8 Latin America Morphine by Country
8.1 Latin America Morphine Historic Market Size by Country
8.1.1 Latin America Morphine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Morphine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Morphine Sales in Value by Country (2018-2023)
8.2 Latin America Morphine Forecasted Market Size by Country
8.2.1 Latin America Morphine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Morphine Sales in Value by Country (2024-2029)
9 Middle East and Africa Morphine by Country
9.1 Middle East and Africa Morphine Historic Market Size by Country
9.1.1 Middle East and Africa Morphine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Morphine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Morphine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Morphine Forecasted Market Size by Country
9.2.1 Middle East and Africa Morphine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Morphine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mallinckrodt Pharmaceuticals
10.1.1 Mallinckrodt Pharmaceuticals Company Information
10.1.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
10.1.3 Mallinckrodt Pharmaceuticals Morphine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Mallinckrodt Pharmaceuticals Morphine Products Offered
10.1.5 Mallinckrodt Pharmaceuticals Recent Development
10.2 Alcaliber
10.2.1 Alcaliber Company Information
10.2.2 Alcaliber Introduction and Business Overview
10.2.3 Alcaliber Morphine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Alcaliber Morphine Products Offered
10.2.5 Alcaliber Recent Development
10.3 Purdue Pharma
10.3.1 Purdue Pharma Company Information
10.3.2 Purdue Pharma Introduction and Business Overview
10.3.3 Purdue Pharma Morphine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Purdue Pharma Morphine Products Offered
10.3.5 Purdue Pharma Recent Development
10.4 Sanofi Winthrop Industrie
10.4.1 Sanofi Winthrop Industrie Company Information
10.4.2 Sanofi Winthrop Industrie Introduction and Business Overview
10.4.3 Sanofi Winthrop Industrie Morphine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Winthrop Industrie Morphine Products Offered
10.4.5 Sanofi Winthrop Industrie Recent Development
10.5 Macfarlan Smith
10.5.1 Macfarlan Smith Company Information
10.5.2 Macfarlan Smith Introduction and Business Overview
10.5.3 Macfarlan Smith Morphine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Macfarlan Smith Morphine Products Offered
10.5.5 Macfarlan Smith Recent Development
10.6 Sun Pharmaceutical Industries
10.6.1 Sun Pharmaceutical Industries Company Information
10.6.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.6.3 Sun Pharmaceutical Industries Morphine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sun Pharmaceutical Industries Morphine Products Offered
10.6.5 Sun Pharmaceutical Industries Recent Development
10.7 Qinghai Pharmaceutical
10.7.1 Qinghai Pharmaceutical Company Information
10.7.2 Qinghai Pharmaceutical Introduction and Business Overview
10.7.3 Qinghai Pharmaceutical Morphine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Qinghai Pharmaceutical Morphine Products Offered
10.7.5 Qinghai Pharmaceutical Recent Development
10.8 Northeast Pharmaceutical Group
10.8.1 Northeast Pharmaceutical Group Company Information
10.8.2 Northeast Pharmaceutical Group Introduction and Business Overview
10.8.3 Northeast Pharmaceutical Group Morphine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Northeast Pharmaceutical Group Morphine Products Offered
10.8.5 Northeast Pharmaceutical Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Morphine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Morphine Industrial Chain Analysis
11.4 Morphine Market Dynamics
11.4.1 Morphine Industry Trends
11.4.2 Morphine Market Drivers
11.4.3 Morphine Market Challenges
11.4.4 Morphine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Morphine Distributors
12.3 Morphine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
